Aardvark Therapeutics Inc (AARD)

May 19, 2025, 4:10 PM EDT - 14 days ago

Aardvark Therapeutics Bolsters Leadership Team with Strategic Hires Across Scientific, Commercial, Regulatory and Legal Functions

May 14, 2025, 4:10 PM EDT - 19 days ago

Aardvark Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Highlights

May 7, 2025, 4:05 PM EDT - 26 days ago

Aardvark Therapeutics to Present at Upcoming Investor Conferences in May

Mar 31, 2025, 4:10 PM EDT - 2 months ago

Aardvark Therapeutics Reports Full Year 2024 Financial Results and Provides Business Highlights

Feb 14, 2025, 11:50 PM EST - 3 months ago

U.S. IPO Weekly Recap: Big Listings Post Mixed Results In Busy 7 IPO Week

AGH KMTS KRMN NPB ODYS SAIL XHLD

Feb 12, 2025, 10:38 PM EST - 3 months ago

Aardvark Therapeutics Announces Pricing of Initial Public Offering

Feb 8, 2025, 2:30 AM EST - 4 months ago

U.S. IPO Weekly Recap: Cement And Cystic Fibrosis Drugs Lead A 6 IPO Week

AGH EPWK FBGL HCAI KRMN NPB ODYS

Feb 3, 2025, 11:52 AM EST - 4 months ago

Aardvark Therapeutics Starts $100 Million IPO Effort For Hunger Treatments

Jan 24, 2025, 5:02 AM EST - 4 months ago

Obesity biotech Aardvark eyes IPO as Ascentage makes $126M Nasdaq debut

Jan 23, 2025, 4:57 PM EST - 4 months ago

Aardvark Therapeutics IPO Registration Document (S-1)